CLPT
ClearPoint Neuro, Inc.
$15.06
-0.61 (-3.89%)
At close · Jul 16
Market Cap
$451.64M
Shares
29,989,563
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$36.97M
+17.8%
FY2025
Net Income
-$25.54M
-35%
FY2025
Gross Margin
61.38%
+0.5pp
FY2025
Operating Margin
-65.36%
-2.5pp
FY2025
Diluted EPS
-$0.90
-28.6%
FY2025
Operating Cash Flow
-$23.9M
-167%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $52M – $56M | $40.61M | $36.97M | $31.39M | $23.96M | $20.55M | $16.3M | $12.83M | $11.22M | $7.35M | $7.38M | $5.75M | $4.59M | $3.6M | $3.93M | $5.06M | $3.82M | $2.67M | |
| — | -$246K | — | $872K | $386K | -$81K | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $15.3M | $14.28M | $12.27M | $10.34M | $7.02M | $5.18M | $3.71M | $3.94M | $2.43M | $2.9M | $2.64M | $1.99M | $1.93M | $1.42M | $555.7K | $656.41K | $16.31K | |
| — | $25.32M | $22.69M | $19.12M | $13.61M | $13.53M | $11.12M | $9.12M | — | — | — | — | — | — | — | — | — | — | |
| — | — | 61.38% | 60.92% | 56.83% | 65.84% | 68.24% | 71.09% | — | — | — | — | — | — | — | — | — | — | |
| — | $15.04M | $13.9M | $12.39M | $11.71M | $10.89M | $9.28M | $4.69M | $2.81M | $2.31M | $2.81M | $2.63M | $1.96M | $3.3M | $2.92M | $2.48M | $4.25M | $5.68M | |
| — | $19.34M | $16.46M | $14.48M | $12.6M | $9.36M | $7.22M | $5.38M | $4.76M | $3.53M | $3.96M | $3.78M | — | — | — | — | — | — | |
| — | $17.41M | $16.5M | $11.99M | $11.76M | $9.61M | $8M | $5.27M | $4.3M | $4.33M | $4.05M | $4.19M | $8.37M | $8.04M | $7.06M | $6.03M | $4.83M | $4.7M | |
| — | — | $168K | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | $814K | $980K | $626K | $244K | $159K | $334K | $144K | $109.44K | $116.45K | $155.71K | $211.95K | $377.26K | $426.18K | $416.97K | $354.89K | $266.22K | |
| — | — | — | — | — | — | — | — | — | — | — | — | $1.25M | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $11.41M | $8.19M | $9.74M | $12.18M | |
| — | -$26.48M | -$24.16M | -$19.73M | -$22.45M | -$16.33M | -$13.37M | -$6.22M | -$4.59M | -$5.25M | -$6.34M | -$7.49M | -$8.97M | -$5.32M | -$7.47M | -$3.13M | -$5.92M | -$9.52M | |
| — | — | -65.36% | -62.87% | -93.7% | -79.47% | -82.05% | -48.48% | -40.96% | -71.37% | -85.86% | -130.25% | -195.34% | -147.61% | -190.17% | -61.87% | -155.09% | -356.45% | |
| — | — | -$23.35M | -$18.75M | -$21.82M | -$16.09M | -$13.22M | -$5.89M | -$4.45M | -$5.14M | -$6.22M | -$7.33M | -$8.76M | -$4.94M | -$7.05M | -$2.71M | -$5.57M | -$9.25M | |
| — | — | $2.39M | $518K | — | $81K | $973K | $1.44M | $955K | $980.38K | $872.93K | $1.05M | $1.26M | $1.02M | $499.84K | $2.59M | $2.5M | $1.59M | |
| — | — | $1.21M | $1.39M | — | — | — | — | — | — | — | $8807 | $16.46K | $11.62K | $24.54K | $14.15K | $3481 | $10.4K | |
| — | -$185K | -$146K | -$40K | -$29K | -$22K | -$63K | $882K | $9000 | $364 | $16.68K | $216.08K | $230.88K | $175.55K | $56.23K | $3586 | $104.85K | $413.62K | |
| — | -$29.02M | -$25.49M | -$18.9M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $45K | $55K | $12K | $8000 | $0 | $0 | $0 | — | — | — | — | — | $0 | $0 | $0 | — | — | |
| — | -$29.07M | -$25.54M | -$18.91M | -$22.09M | -$16.44M | -$14.41M | -$6.78M | -$5.54M | -$6.16M | -$7.17M | -$8.07M | -$8.45M | -$4.52M | -$7.09M | -$5.88M | -$8.31M | -$9.45M | |
| — | — | -69.08% | -60.25% | -92.21% | -79.97% | -88.41% | -52.86% | -49.39% | -83.82% | -97.12% | -140.36% | -183.91% | -125.53% | -180.29% | -116.2% | -217.68% | -354.16% | |
| USD/shares | — | — | -$0.90 | -$0.70 | -$0.90 | -$0.68 | -$0.69 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | — | -$0.90 | -$0.70 | -$0.90 | -$0.68 | -$0.69 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | — | 28.32M | 27.03M | 24.61M | 24.18M | 20.73M | 15.85M | 13.16M | 10.93M | 7.74M | 2.75M | 1.88M | 59.24M | 57.26M | 40.37M | 15.96M | 6.77M |
| shares | — | — | 28.32M | 27.03M | 24.61M | 24.18M | 20.73M | 15.85M | 13.16M | 10.93M | 7.74M | 2.75M | 1.88M | 59.24M | 57.26M | 40.37M | 15.96M | 6.77M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.27×
EV/EBIT
—
Medical Devices median 21.71×
P/E (TTM)
—
Medical Devices median 28.52×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Product | $23,859,000 | $18,626,000 | $10,603,000 | $12,789,000 | $11,913,000 | $8,832,000 |
| Biologics and Drug Delivery | $19,040,000 | $17,310,000 | $13,602,000 | $9,120,000 | $6,795,000 | $5,200,000 |
| Neurosurgery Navigation and Therapy Disposable Products | $14,831,000 | $10,285,000 | — | — | — | — |
| Neurosurgery Navigation and Therapy | $14,831,000 | $10,285,000 | $8,520,000 | — | — | — |
| Service | $13,112,000 | $12,764,000 | $13,352,000 | $7,762,000 | $4,386,000 | $3,997,000 |
| Biologics and Drug Delivery Services and License Fees | $11,702,000 | $11,704,000 | $11,448,000 | $5,430,000 | $3,442,000 | — |
| Biologics and Drug Delivery Disposable Products | $7,338,000 | $5,606,000 | $2,154,000 | $3,690,000 | $3,353,000 | $1,528,000 |
| Capital Equipment and Software | $3,100,000 | $3,795,000 | $1,833,000 | $2,307,000 | $1,433,000 | $1,418,000 |
| Capital Equipment and Software Related Service | $2,100,000 | $2,300,000 | — | — | — | — |
| Capital Equipment and Software Systems and Software Products | $1,690,000 | $2,735,000 | $860,000 | $1,512,000 | $864,000 | $1,093,000 |
| Capital Equipment and Software Services | $1,410,000 | $1,060,000 | $973,000 | $795,000 | $569,000 | $325,000 |
| Biologics and Drug Delivery Services | — | — | — | — | $3,442,000 | $3,672,000 |
| Capital Equipment Related Service Revenue | — | $2,300,000 | $1,100,000 | — | — | — |
| Functional Neurosurgery Navigation And Therapy Disposable Products | — | — | $7,589,000 | $7,587,000 | — | — |
| Functional Neurosurgery Navigation and Therapy | — | — | $8,520,000 | $9,124,000 | $8,071,000 | $6,211,000 |
| Functional Neurosurgery Navigation and Therapy Services | — | — | $931,000 | $1,537,000 | — | — |
| Neurosurgery Navigation and Therapy - Disposable Products | — | $10,285,000 | $7,589,000 | — | — | — |
| Neurosurgery Navigation and Therapy - Services | — | $0 | $931,000 | — | — | — |
| Product_Functional Neurosurgery Navigation And Therapy Disposable Products | — | — | — | $7,587,000 | $7,696,000 | $6,211,000 |
| Product_Functional Neurosurgery Navigation And Therapy Services | — | — | — | $1,537,000 | $375,000 | $0 |